Gaurav Gulati, MD, MS Accepting New Patients

Programs + Specialties	CardioVascular Center
Training + Education	Harvard Medical School; Residency: Hospital of the University of Pennsylvania; Fellowship: Tufts Medical Center
Board Certifications	Internal Medicine, Cardiovascular Disease
NPI #	1124463609
Gender	Male
Accepted Insurances	View Accepted Insurances at Tufts Medical Center

2019, Gold Ribbon Abstract, Association for Clinical and Translational Sciences Scientific Sessions
2019, 1st place Cardiovascular Center Research Symposium Poster Competition, Tufts Medical Center

Gulati G, Zhang K, Scherrer-Crosbie M, Ky B. Cancer and cardiovascular disease: the use of novel echocardiography measures to predict subsequent cardiotoxicity in breast cancer treated with anthracyclines and trastuzumab. Curr Heart Fail Rep 2014; 11(4): 366–373.

Shahul S, Gulati G, Hacker M, Mahmood F, Canelli R, Nizamuddin J, Mahmood B, Mueller A, Simon B, Novack V, Talmor D. Detection of myocardial dysfunction in septic shock: a speckle tracking echocardiographic study. Anesth & Analg 2015; 121(6):1547–1554.

Zhang K*, Finkelman B*, Gulati G*, Narayan H, Upshaw J, Narayan V, Plappert T, Engelfield V, Smith AM, Zhang C, Hundley G, Ky B. Abnormalities in 3-dimensional left ventricular mechanics with anthracycline chemotherapy are associated with systolic and diastolic dysfunction. J Am Coll Cardiol Cardiovasc Imaging 2018; 11(8):1059–1068.

Gulati G, Udelson J. Heart failure with improved ejection fraction: Is it possible to escape one’s past? J Am Coll Cardiol HF 2018, 6(9): 725–733.

Gulati G, Grandin EW, Kennedy K, Cabezas F, DeNofrio D, Kociol R, Rame JE, Pagani F, Kirklin J, Kormos R, Teuteberg J, Kiernan M. Pre-implant phosphodiesterase-5 inhibitor use is associated with higher rates of severe early right heart failure after LVAD implantation: An INTERMACS analysis. Circulation HF 2019; 12(6):e005537.

Gulati G, Kiernan M, Sabe M. Massive retroperitoneal hemorrhage after external shock wave lithotripsy in a patient with a left ventricular assist device. Urology Case Reports 2020; 28:101033.

Gulati G, Sutaria N, Vest AR, DeNofrio D, Kawabori M, Couper G, Kiernan M. Timing and trends of right atrial pressure and risk of right heart failure after left ventricular assist device implantation. Journal of Cardiac Failure, 2020; 26(5):394–401.

Roehm B, Gulati G, Weiner D. Heart Failure Management in Dialysis Patients: Many Treatment Options with No Clear Evidence. Seminars in Dialysis. 2020; 33(3):198–208.

Gulati G, Ruthazer R, DeNofrio D, Vest AR, Kent D, Kiernan M. Understanding Longitudinal Changes in Pulmonary Vascular Resistance After Left Ventricular Assist Device Implantation. Journal of Cardiac Failure, 2021; 27(5):552–559.

Wessler BS, Nelson J, Park JG, McGinnes H, Gulati G, Brazil R, van Calster B, van Klaveren D, Venema E, Steyerberg E, Paulus JK, Kent DM. External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature. Circ Cardiovasc Qual Outcomes. 2021; 14(8):e007858.

Gaurav Gulati, MD is a cardiologist in Advanced Heart Failure and Transplant Cardiology and an Assistant Professor of Medicine at Tufts University School of Medicine. He specializes in cardiomyopathies, heart failure, heart transplantation, ventricular assist devices and cardiogenic shock. His research focus areas include hemodynamics, pulmonary hypertension, LVAD management and right heart failure. In 2019 he received the Gold Ribbon Abstract from the Association for Clinical and Translational Sciences Scientific Sessions. The same year he was awarded first place in the CardioVascular Center Research Symposium Poster Competition, Tufts Medical Center. He is a member of the American College of Cardiology, Heart Failure Society of America and The International Society for Heart and Lung Transplantation.

American College of Cardiology
Heart Failure Society of American
The International Society for Heart and Lung Transplantation